CTOs on the Move

Apos Therapy

www.apostherapy.com

 
AposTherapy provides a clinically proven, innovative, drug-free, at-home treatment for reducing pain and improving function in patients suffering from knee osteoarthritis and chronic lower back or hip pain.
  • Number of Employees: 100-250
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Funding

Apos Therapy raised $11M on 02/17/2020

Similar Companies

Wellteq

Wellteq is creating the future of precision wellness through a digital wellbeing ecosystem taking users from point of prevention through to point of care. Delivered into the corporate health and insurance sector to drive user engagement through a personalised wellness journey. wellteq uses a range of data types from wearable devices, sensors, biomarkers and user-generated data that, in combination with machine learning and artificial intelligence enables individual-level insights into Stress, Fatigue, Sleep Quality, Cognitive Function and Activity levels. Behavioural science and content targeting use biometric and behavioural analytics to deliver personalised wellness insights and practical recommendations to build engagement, agency and more effective sustainable management of personal wellness. Programs are highly customisable and provide an experience packed with gamification, group projects, social interaction rewards and charity all to maximise healthy behavioural change. With customisation comes flexibility, which is paramount for businesses of all shapes and sizes around the world today.

Bard Access Systems

Bard Access Systems is a Salt Lake City, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Community Health Net Medical

Community Health Net offers a range of healthcare services for newborn through geriatric patients.

Trailblazer Health Enterprises

Trailblazer Health Enterprises, LLC is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EndoGastric Solutions

Based in Redmond, WA, EndoGastric Solutions, Inc., is a medical device company focused on developing and commercializing innovative, evidence-based, incisionless surgical technology for the treatment of gastroesophageal reflux disease (GERD). EGS has combined the most advanced concepts in gastroenterology and surgery to develop the Transoral Incisionless Fundoplication (TIF®) procedure—a minimally invasive solution that addresses a significant unmet clinical need.